Abstract:BackgroundIn haemato-oncologic patients bacteremia is frequent increasing mortality rates, therefore surveillance and close follow up is essential to optimize treatment. The use of invasive devices used frequently in this population increases the incidence of infections by gram-positive microorganisms (currently gram-negative bacilli have been added). Therefore, we propose the characterization the microorganisms to identify the epidemiologic conditions, and the areas of improvement to establish improvement care strategies for this population.MethodsWe conducted a retrospective study at the haemato-oncologic diseases service at the National Medical Center "20 de Noviembre". Prevalence of bacteremia in pediatric patients with cancer and neutropenia in Mexican population, which ranges from 8% to 36%, assuming that our results could be similar to higher percentage, employing a proportion formula with a study population of 65 patients.ResultsIt was demonstrated in our population studied that in all cases of bacteremia, patients were in depth neutropenia at diagnosis. The most prevalence phase of chemotherapy was Induction phase (69.2%), with Total XV ST Jude protocol. The clinical data revealed the following frequencies in 100% of the patients: Fever (92%), Tachycardia (72%), Shivering and piloerection (65%), Elevated acute-phase reactants PCT (51%), CPR (32%), and Tachypnea (28%). Cases of Central Line-associated Bloodstream Infection (CLABSI) was reported in 86.2%, affecting individuals with vascular devices. The predominant microbiological isolate in our patients was Escherichia coli ESBL (31%), followed by Klebsiella pneumoniae (18%), and Pseudomonas aeruginosa (13.8%), Staphylococcus epidermidis (11%). Other bacteria were identified at even lower frequencies, such as Stenotrophomonas maltophilia (5%), Klebsiella oxytoca (5%), Staphylococcus aureus (3%), Serratia marcescens (3%), Enterococcus faecalis (3%), and Enterobacter cloacae (3%). The least observed in our population was the identification of Acinetobacter bauman nii (2%). The different outcomes recorded in our sample were highly consistent, with a resolution rate of infection in 97% of cases and 3% of cases resulting in death attributable to bacteremia (Table 1).ConclusionThe low mortality found in this study may be due to the early initiation of empirical antibiotic treatment in "golden hour", a protocol carried out in our Center, as well as the identification of severity scales.Table 1 General characteristics of children with bacteremia and malignant neoplasiaTotaln = 65 Neoplasm TypepHematologicaln = 48 Solidn = 17 Age, years8.13 ± 3.77.83 ± 3.79.00 ± 3.770.276Gender Female Male41 (63%)24 (37%)34 (71%)14 (29%)7 (41%)10 (69%)0.059Invasive Devices Without invasive devices Vascular catheter Urinary catheter Endotrachealtube Others2 (3%)63 (97%)9 (14%)8 (12%)1 (2%)2 (4%)46 (96%)8 (17%)5 (10%)1 (2%)017 (100%)2 (12%)2 (12%)00.96990.96990.928111 Depth Neutropenia Days65 (100%)9 (6 – 12)48 (100%)10 (6.5 - 11.5)17 (100%)7 (5.2 – 13.5)NA: 0.4931 * Microbiológical isolation Escherichia coli Klebsiella pneumoniae Pseudomonas aeruginosa S. Epidermidis S. Maltophilia Klebsiella oxytoca Staphyloccocus Aureus Serratia marcescens Enterococcus faecalis Enterobacter cloacae Staphyloccocus hominis Acinetobacter baumannii 21 (32%)12 (18%)9 (13.8%)7 (11%)3 (5%)3 (5%)2 (3%)2 (3%)2 (3%)2 (3%)1 (2%)1 (2%)18 (38%)10(21%)8 (17%)5 (10%)2 (4%)1 (2%)1 (2%)2 (4%)2 (4%)2 (4%)1 (2%)1 (2%)3 (18%)2 (12%)1 (6%)2 (12%)1 (6%)2 (12%)1 (2%)00000NAHospital stay (days)25(17.5 – 29.5)26(17.5 – 29.5)24(17.2 – 29.5)0.9107 * Outcome Infection resolved Attributable death63 (97%)2 (3%)46 (96%)2 (4%)17 (100%)00.9699

Stenotrophomonas maltophilia bacteremia in hemato-oncological patients

Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate

Retrospective Analysis Of Stenotrophomonas Maltophilia Bacteremia: Clinical Features, Risk Factors And Therapeutic Choices

Stenotrophomonas maltophilia bacteremia in children - A 10-year analysis

Fatal Hemorrhagic Pneumonia in Patients with Hematologic Diseases and Stenotrophomonas Maltophilia Bacteremia: a Retrospective Study

Stenotrophomonas maltophilia bacteremia in adult patients with hematological diseases: clinical characteristics and risk factors for 28-day mortality

Bacteremia due to glucose non-fermenting gram-negative bacilli in patients with hematological neoplasias and solid tumors

Empirical polymyxin B therapy in febrile neutropenic patients with hematological diseases: A prospective, multicenter, observational clinical study

720Clinical Features and Risk Factors for Mortality of Stenotrophomonas Maltophilia Bacteremia in Patients with Hematologic Malignancies

Successful treatment of pulmonary haemorrhage and acute respiratory distress syndrome caused by fulminant Stenotrophomonas maltophilia respiratory infection in a patient with acute lymphoblastic leukaemia - case report

Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy

Risk Factors for Infection and Mortality Associated With Stenotrophomonas maltophilia Bloodstream Infections in Children; Comparison With Pseudomonas aeruginosa Bloodstream Infections

Hemorrhagic Pneumonia in a Kidney Transplant Recipient Caused by Stenotrophomonas Maltophilia Infection: A Case Report

Clinical Features, Outcomes, and Risk Factors of Bloodstream Infections due to Stenotrophomonas maltophilia in a Tertiary-Care Hospital of China: A Retrospective Analysis

Risk Factors of Stenotrophomonas maltophilia Blood Stream Infections: Comparison With Other Gram-Negative Blood Stream Infections in Children

Alterations of the Oral Microbiome and Cumulative Carbapenem Exposure Are Associated With Stenotrophomonas maltophilia Infection in Patients With Acute Myeloid Leukemia Receiving Chemotherapy

Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997–2004

Stenotrophomonas maltophilia neonatal sepsis: a case report

Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital

Stenotrophomonas maltophilia Epidemiology, Resistance Characteristics, and Clinical Outcomes: Understanding of the Recent Three Years' Trends

Bacteremias in Hemato-Oncological Pediatric Patients: Clinical and Microbiological Characteristics